Skip to main content
Solventum logo

Solventum

3.7
SOLV

A Solventum Company

www.solventum.com
Location
Saint Paul, MN
Size
10,001+ employees
Revenue
$5 to $10 billion (USD)
Industry
Medical Equipment Manufacturing
Founded
2024

Solventum: Healthcare Innovation Powerhouse

Solventum emerged in April 2024 as an independent healthcare innovation leader, spinning off from 3M with a bold mission to revolutionize patient care through breakthrough solutions. Headquartered in Saint Paul, Minnesota, this dynamic company employs over 20,000 professionals across 38 countries, generating approximately $8.2 billion in revenue while operating more than 300 global facilities that serve healthcare providers worldwide.

Innovation At the Intersection of Science

Operating through four strategic divisions-MedSurg, Dental Solutions, Health Information Systems, and Purification & Filtration-Solventum delivers cutting-edge products that merge health, material, and data sciences. From advanced wound care solutions and iconic Littmann stethoscopes to sophisticated health information systems and biopharmaceutical purification technologies, the company's comprehensive portfolio addresses critical healthcare challenges with scientific precision and compassionate purpose.

Culture Rooted In Purpose

Five core values guide every initiative: Put people first, Win with excellence, Solve what matters, Advance together, and Live with heart. This distinctive approach combines cutting-edge technology with empathy and compassion, creating an environment where healthcare professionals can pursue meaningful careers while contributing to humanity's advancement.

Career Growth and Development

  • Multi-year growth strategy creating new opportunities across diverse healthcare sectors
  • Strong commitment to sustainability and social impact initiatives
  • Global presence with opportunities in North America, Europe, and emerging markets
  • Leadership focused on maximizing brand portfolio potential and employee development
  • Work environment that prioritizes both professional excellence and personal fulfillment

Making a Meaningful Impact

Under CEO Bryan Hanson's leadership, Solventum recognizes that 80-90% of health outcomes stem from social determinants of health, driving the company's commitment to addressing global health inequalities. Team members join a culture where innovation directly improves patient lives while advancing healthcare sustainability. Every scientific advancement pursued melds the latest technology with compassion, ensuring solutions that change lives for the better.

Mission

Enabling better, smarter, safer healthcare to improve lives.

Frequently Asked Questions

Solventum employs over 20,000 professionals across 38 countries, operating more than 300 global facilities that serve healthcare providers worldwide.

Offices

Loading map...

Solventum Reports Third Quarter 2025 Financial Results

Reported sales increased 0.7%; organic sales increased 2.7% Expects full year organic sales growth to be at the high end of +2.0% to +3.0% range Increases full year adjusted earnings per share outlook to $5.98 to $6.08 Announces 4-year 'Transform for the Future' initiative ST. PAUL, Minn., Nov. 6, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Sales increased 0.7% to $2.1 billion; up...

Read Full Article

Solventum to Participate in the 2025 Stifel Healthcare Conference

ST. PAUL, Minn., Nov. 3, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today its executives will participate in a fireside chat at the Stifel Healthcare Conference on Wednesday, Nov. 12, 2025, beginning at approximately 11:20 a.m. EST in New York, NY. A live and archived replay of the fireside chat will be available on the company's website at investors.solventum.com. About Solventum At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a...

Read Full Article

Solventum Appoints Heather Knight as Chief Commercial Officer

ST. PAUL, Minn., Oct. 21, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today the appointment of Heather Knight as Chief Commercial Officer, effective November 10, 2025. In this newly created role, Ms. Knight will oversee global commercial and R&D operations across Solventum's MedSurg, Dental Solutions and Health Information Systems segments, and will report directly to CEO Bryan Hanson. Ms. Knight brings over 30 years of leadership experience in the MedTech industry. Most recently,...

Read Full Article

Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025

ST. PAUL, Minn., Oct. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its third quarter fiscal 2025 financial results on Thursday, Nov. 6, 2025, after the U.S. financial markets close. After the release, Solventum management will host a webcast to discuss the results and its business. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Date: Thursday, Nov. 6, 2025 Time: 3:30 p.m. CST / 4:30 p.m. EST Location:...

Read Full Article

Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025

ST. PAUL, Minn., July 17, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its second quarter fiscal 2025 financial results on Thursday, Aug. 7, 2025, after the U.S. financial markets close. After the release, Solventum management will host a webcast to discuss the results and its business. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Date: Thursday, Aug. 7, 2025 Time: 3:30 p.m. CDT / 4:30 p.m. EDT Location:...

Read Full Article